Inhibitors of Membranous Adenylyl Cyclases - PMC - PubMed …
Studies with mAC gene knockout mice provide evidence for the notion that AC isoforms play distinct (patho)physiological roles. Consequently, there is substantial interest in the development of isoform-selective mAC inhibitors. Here, we review the current literature on mAC inhibitors.
Adenylyl Cyclases - Basic Neurochemistry - NCBI Bookshelf
G αi-mediated inhibition of adenylyl cyclase is most dramatic for the type V and type VI enzymes. Type I adenylyl cyclase also can be inhibited by these G αi subtypes, as well as by G αo, but this inhibition is observed more readily when the type I enzyme …
Adenylate Cyclase Inhibitor - an overview | ScienceDirect Topics
Over forty years ago, the bisphenol hexachlorophene was identified as an inhibitor of mammalian adenylyl cyclase activity (Mavier, Stengel, & Hanoune, 1976), and we showed recently that it specifically inhibits sAC (Kleinboelting et al., 2016). Both hexachlorophene and the related bisphenol bithionol inhibit sAC by binding to the bicarbonate ...
Capturing adenylyl cyclases as potential drug targets
Cyclic AMP (cAMP) is generated by nine membrane-bound adenylyl cyclases (AC1–AC9) and one soluble isoform (sAC). Many drugs target cAMP signalling pathways through their respective G-protein...
Structure and function of adenylyl cyclases, key enzymes in …
2020年8月1日 · Adenylyl cyclases (ACs) are the enzymes that generate cAMP, and thus the key components of the cAMP signaling and regulation pathways. In this review we provide a brief general overview of the field, focusing on the recent breakthroughs in our understanding of the structure and function of the ACs as the key enzymes in cellular signaling.
Identification of FDA-Approved Small Molecules Capable of …
Adenylyl cyclases (AC) catalyze the formation of cyclic AMP (cAMP) from ATP and are involved in a number of disease states, making them attractive potential drug targets. AC8, in particular, has been implicated in several neurological disorders.
Functional and pathological roles of adenylyl cyclases in various ...
2024年11月1日 · ADCY3 is a new molecular target for gastric cancer. In liver diseases, the regulation of the cAMP signal can treat alcohol-related liver diseases. sAC is a potential therapeutic target for primary biliary cholangitis. sAC LRE1 inhibitor can prevent hepatic ischemia/reperfusion injury.
Identification of a selective small-molecule inhibitor of type 1
2017年2月21日 · Brust et al. identified a small-molecule inhibitor of adenylyl cyclase 1 (AC1), which is a potential target for treating pain and reducing the dependency on opioids for pain management.
Discovery of TDI-10229: A Potent and Orally Bioavailable Inhibitor …
Soluble adenylyl cyclase (sAC) has gained attention as a potential therapeutic target given the role of this enzyme in intracellular signaling. We describe successful efforts to design improved sAC inhibitors amenable for in vivo interrogation of sAC inhibition to assess its potential therapeutic applications.
Adenylyl Cyclases - SpringerLink
2020年4月22日 · Inhibition of adenylyl cyclase by Gα i occurs through the interaction with the analogous Gα s site in the C 1 domain of adenylyl cyclase. The structure obtained with β-L-2′,3′-dd-5′-ATP (a competitive inhibitor of ATP binding) allowed the demonstration that the pseudosymmetric cleft formed by the interface of the C 1 • C 2 domains ...
- 某些结果已被删除